ACRS vs CLOV
Aclaris Therapeutics Inc (ACRS) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ACRS revenue for 2024-12-31 was $18.7M. Net income was -$132.1M. Revenue was down 40.1% from 2023-12-31 to 2024-12-31. ACRS currently screens at market cap $615.9M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ACRS currently screens at market cap $615.9M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ACRS and CLOV stock pages for the full models.
Not investment advice.